Katedra Transplantologii i Chirurgii Ogólnej

Szpital Uniwersytecki nr 1 im. dr. A. Jurasza
ul. Curie Skłodowskiej 9, 85-094 Bydgoszcz
tel.: +48 52 585 34 80

obrazek nr 1

Katedra Transplantologii i Chirurgii Ogólnej

Kierownik Katedry: prof. dr hab. n. med. Zbigniew Włodarczyk
Kierownik Katedry: prof. dr hab. n. med. Zbigniew Włodarczyk

W skład Katedry wchodzi:

  • Klinika Transplantologii i Chirurgii Ogólnej
    kierownik: prof. dr hab. n. med. Zbigniew Włodarczyk
    e-mail: wlodarczyk@cm.umk.pl

Badania naukowe:

2012
A Phase 3, Double-Blind, Double-Dummy, Multi-Center, prospective, Randomized Study of the Efficacy and Safety of LCP-Tacro Tablets, Once Daily, compared to Prograf Capsules, Twice daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients.

A Three-Part, Multi-Centre, Randomised, Double Blind, Placebo-Controlled, Parallel-Group, Sequential Adaptive, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of OPN305, a Humanised Monoclonal Antibody that Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function.

2007
Efficacy and Safety of Alefacept in Combination with Tacrolimus, Mycophenolate Mofetil and Steroids in De-Novo Kidney Transplantation – a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parellel Group Study.

A Long-Term Follow Up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated with Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen.

2005
VICTOR Study – (MT17973) Valcyte in CMV-disease treatment of solid organ recipients
Open Randomized Study to Evaluate Efficacy and safety of Oral Valgancyclovir Versus IV Ganciclovir for the Treatment of CMV Disease in Solid Organ Transplant Recipients

2003
A Multicentre, Randomised, Double-blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 with Tacrolimus (FK506) and Steroids versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients.